Observational case series on a group of patients with severe psoriasis who failed to respond to antitumour necrosis factor alpha biologics and switched to ustekinumab.

• Authors: A M R Downs
• Journal: The British journal of dermatology (Br J Dermatol) Vol. 163 Issue 2 Pg. 433-4 (Aug 2010) ISSN: 1365-2133 [Electronic] England
• PMID: 20456344 (Publication Type: Comment, Letter)

Chemical References

• Antibodies, Monoclonal
• Antibodies, Monoclonal, Humanized
• Dermatologic Agents
• Immunologic Factors
• Tumor Necrosis Factor-alpha
• Ustekinumab

Topics

• Antibodies, Monoclonal (therapeutic use)
• Antibodies, Monoclonal, Humanized
• Dermatologic Agents (therapeutic use)
• Humans
• Immunologic Factors (therapeutic use)
• Psoriasis (drug therapy)
• Treatment Failure
• Tumor Necrosis Factor-alpha (antagonists & inhibitors)
• Ustekinumab